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Abstract
The studies show that HIV/AIDS disease had and is having a high im-
pact on Populations' health but it represents serious socioeconomic 
problems added for individuals, families, communities and Govern-
ments of many countries. In Brazil, the National Standardization Panel 
of the Federal Courts, the body that comprises the Brazilian National 
Council of Justice, drafted the docket 78. From this docket, to grant 
or deny the social security benefit, the judges will not have their de-
cisions limited only to the clinical aspects of medical experts report, 
starting to also consider the personal, economic, social and cultural 
aspects of the HIV patient. By analyzing the cases heard by Federal 
Court of the 5th Region, which constitutes the Brazilian states of Pa-
raíba, Pernambuco, Rio Grande do Norte, Ceará, Alagoas and Sergipe, 
fourteen cases were found on appeal of special courts. Within those 
cases, ten were founded to be HIV positive and were granted some 
sort of pension and welfare benefit, and four were rejected, den-
ying incoming thus those patients with syndrome, the right to receive 
benefits. The Brazilian Federal Government through the Provisional 
Measure no 664 from 2014 excluded the art. 151 of the Federal Law 
8. 213/91 which dealt with the granting sickness benefit and disability 
retirement to patients with various disabling conditions which among 
the HIV saving a total of 18 million to public coffers. The authors point 
out that the exclusion or this article constitutes the loss of benefits 
–sickness assistance and disability retirement– those who do not have 
a minimum period of contribution to Social Security. That constitutes 
prejudice to the HIV patient´s rights in relation helpless leaving them 
to State coverage. In this context HIV/AIDS diagnosis not only adver-
sely affects individual health and survival but may be associated with 
higher also need for care, thus resulting in higher expenses for the 
healthcare system. 
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An estimated 34 million people are infected with 
Human Immunodeficiency Virus (HIV) worldwide 
[1]. There are 1. 1 million HIV-positive individuals 
living in the Unites States [2] and of nine countries 
where HIV incidence increased by more than 25% 
between 2001 and 2011, six are in eastern Europe 
and central Asia [3]. In the year 2012, 39,185 cases 
of AIDS were reported in Brazil. The national ave-
rage was 20. 2 cases per 100, 000 inhabitants, to 
which in the last 10 years the country has suffered 
an increase of about 2% in the rates of seropositive 
patients [4]. 
At the same time, the cost of antiretroviral thera-
py has gradually increased from about €92 million 
in 2004 to more than €193 in 2010 as Italian stu-
dy [5]. In Spain, the estimated treatment cost per 
patient-year is €11,638, with an SD of €3,756. The 
approximate annual cost of treating these patients 
in Germany is €32,110 (SD €6,960). For France, 
the estimated per-person annual treatment cost is 
€14,821 (SD €1,897). Lastly, it was found that the 
mean cost of this treatment per patient-year in the 
United Kingdom was €25,340 (SD €14,549) [6]. In 
Brazil, between the years of 2005 and 2013, the 
access to treatment has been increased from 165, 
000 (2005) to 400,000 (2014) treated patients, with 
the prospect of R $ 36 million invested in 2014 [7]. 
Several studies have documented the complex 
relation between socioeconomic context and the 
spread of infectious diseases [8]. Deleterious eco-
nomic effects of HIV/AIDS on individuals and hou-
seholds include reduced income, reallocation and 
consumption of assets, savings and resources [9]. 
Its management involves the treatment of AIDS-
associated symptoms and opportunistic infections, 
and other costs associated with morbidity/prematu-
re mortality of adult working patients [10]. 
The National Standardization Panel of the Federal 
Courts, the body that comprises the Brazilian Natio-
nal Council of Justice, drafted the docket 78. Thus, 
to grant or deny the social security benefit, the jud-
ges will not have their decisions limited only to the 
clinical aspects of medical report experts, starting 
to also consider the personal, economic, social and 
cultural aspects of the HIV patient [11, 12]. 
By analyzing the cases heard by the Federal Court 
of the 5th Region, which constitutes the Brazilian 
states of Paraíba, Pernambuco, Rio Grande do Nor-
te, Ceará, Alagoas and Sergipe, fourteen cases were 
found on appeal of special courts [13]. Within those 
cases, 10 were founded to be HIV positive and were 
granted some sort of pension and welfare benefit, 
and 04 were rejected, thus denying those patients 
with the syndrome, the right to receive benefits 
(Table 1). 
It is noteworthy that most of the favorable deci-
sions were based on the fact that the State has the 
duty to seek public policies that guarantee survival 
for patients with diseases, not only with medical 
help, but social support, ensuring a minimum of 
dignity to the HIV-positive patient, according to the 
prerogatives of Article 5 of the Constitution of 1988 
[14]. Thereby, the HIV/AIDS disease not only had and 
is having a high impact on populations’ health but 
it represents serious added socioeconomic problems 
for individuals, families, communities and govern-
ments of many countries [15]. 
The rejected cases were based on expert medical 
reports from the National Institute of Social Securi-
ty, which show that the AIDS generates discomfort 
and some limitations, but not significantly reflected 
in the performance of normal work activities, not 
demonstrating any physical or mental disability for 
independent living or to work. According to literatu-
re for the positive HIV worker, physical and psycho-
logical issues, like fatigue and cognitive impairment 
are a problem for optimal functioning at work [16]. 
Stigma and discrimination also seem to be the main 
employment-related problems for people with HIV 
[17]. 
Another justification for the invalid cases heard is 
that there is no emergence of occupational diseases 
that render impossible to work or simply that cer-
tain activities that have greater contact with people 
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Table 1.  Judged proceeding relating to the application for receiving social security benefits from 2012 to 
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*OLSA- Organic Law of Social Assistance
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generates greater presence of prejudice and discri-
mination. Literature argues that persons with seve-
re mental illness (SMI) have high rates of HIV-risk-
related behaviors [18]. Major depression is highly 
prevalent among HIV-positive patients [19]. 
The Brazilian Federal Government through Provi-
sional Measure number 664 in 2014 excluded the 
art. 151 of the Federal Law 8. 213/91 which dealt 
with the granting of sickness allowance and disa-
bility retirement to patients with various disabling 
conditions among which HIV [20] saving a total of 
18 million to public funds. The exclusion of this ar-
ticle constitutes a loss of benefits –sickness allowan-
ce and disability retirement– for those who do not 
have a minimum period of contribution to Social 
Security. This is prejudice to the right of HIV pa-
tients, leaving them helpless in relation to state co-
verage. In this context HIV/AIDS diagnosis not only 
adversely affects individual health and survival but 
may also be associated with higher need for care, 
thus resulting in higher expenses for the healthcare 
system [21]. 
Therefore, the pension system being contributory, 
there is no way to be disengaged from the social, 
economic and cultural reality of the country, where 
social problems require the law to shape up and 
reinvent itself to meet the demands of the popu-
lation. In the context of Social Security Law, the 
docket 78 of the National Standardization Panel in-
novates by showing that the increased support to 
HIV-positive patient promoted by State should be 
a priority, especially when considering the indivi-
dual socioeconomic spheres. This brief also points 
out the need to integrate the law to the structural 
efforts and interventions to improve social support 
and/or reduce HIV-related stigma. 
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